BL
BlossomHill Therapeutics, Inc.
BLSM · NASDAQ
$25.25 -4.25% (-$1.12)
1M +57.52%
Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 0.00x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BLSM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jing Rong Jean Cui
Employees
63
Headquarters
San Diego